Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Gottlieb, 1993, Hemodynamic and neurohumoral effects of the angiotensin II antagonist losartan in patients with congestive heart failure, Circulation, 88, 1602, 10.1161/01.CIR.88.4.1602 Crozier, 1995, Losartan in heart failure. Hemodynamic effects and tolerability, Circulation, 91, 691, 10.1161/01.CIR.91.3.691 Dickstein, 1995, Comparison of the effects of losartan and enalapril on clinical status exercise performance in patients with moderate or severe chronic heart failure, J Am Coll Cardiol, 26, 438, 10.1016/0735-1097(95)80020-H Pitt, 1997, Randomized trial of losartan versus captopril in patients over 65 with heart failure, Lancet, 349, 747, 10.1016/S0140-6736(97)01187-2 Urata, 1990, Angiotensin II-forming pathways in normal and failing human hearts, Circ Res, 69, 883, 10.1161/01.RES.66.4.883 Francis, 1984, The neurohumoral axis in congestive heart failure, Ann Intern Med, 101, 370, 10.7326/0003-4819-101-3-370 Cohn, 1984, Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure, N Engl J Med, 311, 819, 10.1056/NEJM198409273111303 Packer, 1988, Neurohormonal interactions and adaptations in congestive heart failure, Circulation, 77, 721, 10.1161/01.CIR.77.4.721 Remes, 1991, Neuroendocrine activity in untreated heart failure, Br Heart J, 65, 249, 10.1136/hrt.65.5.249 Swedberg, 1990, Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality, Circulation, 82, 1730, 10.1161/01.CIR.82.5.1730 Rouleau, 1994, Prognostic value of neurohumoral activation in patients with an acute myocardial infarction, J Am Coll Cardiol, 24, 583, 10.1016/0735-1097(94)90001-9 Levine, 1990, Elevated circulating levels of tumor necrosis factor in severe chronic heart failure, N Engl J Med, 323, 236, 10.1056/NEJM199007263230405 Mann, 1994, Basic mechanisms in congestive heart failure, Chest, 105, 897, 10.1378/chest.105.3.897 Ferrari, 1995, Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure, Circulation, 92, 1479, 10.1161/01.CIR.92.6.1479 Finkel, 1992, Negative inotropic effects of cytokines on the heart mediated by nitric oxide, Science, 257, 387, 10.1126/science.1631560 Pagani, 1992, Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs, J Clin Invest, 90, 389, 10.1172/JCI115873 Hegewish, 1990, TNF-induced cardiomyopathy, Lancet, 2, 294, 10.1016/0140-6736(90)90115-L Bozkurt, 1998, Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats, Circulation, 97, 1382, 10.1161/01.CIR.97.14.1382 Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. 1998;97:1375\N81. Hirota, 1995, Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice, Pro Natl Acad Sci USA, 92, 4862, 10.1073/pnas.92.11.4862 Yoshida, 1996, Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders, Pro Natl Acad Sci USA, 93, 407, 10.1073/pnas.93.1.407 Torre-Amione, 1996, Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction, J Am Coll Cardiol, 27, 1201, 10.1016/0735-1097(95)00589-7 Tsutamoto, 1998, Interleukin-6 spillover in peripheral circulation increases with the severity of heart failure, and the high plasma interleukin-6 level is an important prognostic predictor of patients with congestive heart failure, J Am Coll Cardiol, 31, 391, 10.1016/S0735-1097(97)00494-4 Beasly, 1997, Phorbol ester and interleukin-1 induce interleukin-6 gene expression in vascular smooth muscle cells via independent pathways, J Cardiovasc Pharmacol, 29, 323, 10.1097/00005344-199703000-00004 Han, 1999, Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kB transcription factor, Circ Res, 84, 695, 10.1161/01.RES.84.6.695 Hahn, 1994, Activation of human peripheral monocytes by angiotensin II, FFBS Letters, 347, 178, 10.1016/0014-5793(94)00531-1 Mervaala, 1999, Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension, Hypertension, 33, 389, 10.1161/01.HYP.33.1.389 Gottlieb, 1989, Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure, J Am Coll Cardiol, 13, 1534, 10.1016/0735-1097(89)90344-6 Omland, 1996, Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction, Circulation, 93, 1963, 10.1161/01.CIR.93.11.1963 Tsutamoto, 1997, Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure, Circulation, 96, 509, 10.1161/01.CIR.96.2.509 Yasue, 1994, Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure, Circulation, 90, 195, 10.1161/01.CIR.90.1.195 Tsutamoto, 1992, Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure, J Am Coll Cardiol, 20, 541, 10.1016/0735-1097(92)90005-8 Tsutamoto, 1993, Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure, Circulation, 87, 70, 10.1161/01.CIR.87.1.70 Wada, 1994, Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors, Circulation, 89, 2232, 10.1161/01.CIR.89.5.2232 Huang, 1986, In vivo evidence that cGMP is the second messenger for atrial natriuretic factor, Pro Natl Acad Sci USA, 83, 8015, 10.1073/pnas.83.20.8015 Maeda, 1997, Chronic effects of ANG II antagonist in heart failure, Am J Physiol, 272, H2139 Tsutamoto, 1994, Relation between endothelin-1 spillover in the lungs and pulmonary vascular resistance in patients with chronic heart failure, J Am Coll Cardiol, 23, 1427, 10.1016/0735-1097(94)90387-5 Tsutamoto, 1995, Prognostic value of plasma intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure, Am J Cardiol, 76, 803, 10.1016/S0002-9149(99)80231-8 Smith, 1987, Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor, Am J Physiol, 253, C147, 10.1152/ajpcell.1987.253.1.C147 Tsutsumi, 1998, Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression, Circ Res, 83, 1035, 10.1161/01.RES.83.10.1035 Egidy, 1997, CGP-42112 partially activates human monocytes and reduces their stimulation by lipopolysaccharides, Am J Physiol, 273, C826, 10.1152/ajpcell.1997.273.3.C826